Celldom

Celldom is a private, pre-revenue platform company founded in 2016, focusing on advanced live cell analysis. Its core technology automates the processing and multi-parameter analysis of over 100,000 single cells per plate, capturing secreted proteins, morphology, migration, gene expression, and surface proteins over time without complex microfluidics. The platform aims to address critical bottlenecks in identifying rare cells and characterizing dynamic cell-cell interactions, which are essential for cell therapy development and bioprocessing. Celldom's approach provides a unique tool for researchers and developers needing functional, longitudinal data at single-cell resolution.

Live single-cell biology platform using microwell arrays and AI-driven analytics to perform real-time, high-throughput, multi-parameter functional analysis (including secreted protein detection, morphology, migration, gene expression, surface proteins) on individual cells over time under standard culture conditions.

Celldom competes in the single-cell analysis market against established players like 10x Genomics (genomics-focused), Sartorius (Incucyte live-cell imaging), and Berkeley Lights (optofluidic cell selection). Its key differentiation is the combination of long-term live-cell imaging, high-throughput secretome analysis, and AI-driven behavioral tracking without complex microfluidics.